Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Metropolis Healthcare Ltd. (METROPOLIS) Stock Price & Analysis

3 Followers

METROPOLIS Stock Chart & Stats

₹582.05₹13.30(2.34%)
At close: 3:30 PM GMT+5:30
₹525₹550₹575₹600Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
INR 548.45 - INR 585.30
52-Week Range
INR 413.00 - INR 608.95
Previous Close
INR 568.75
Volume
N/A
Average Volume (3M)
10.55K
Market Cap
INR 116.19B
Enterprise Value
INR 112.69B
Total Cash (Recent Filing)
INR 2.03B
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
58.4
Beta
0.70
Next Earnings
Feb 10, 2027 (Est.)
EPS Estimate
2.83
Last Dividend Ex-Date
May 19, 2026
Dividend Yield
0.35%

Bulls Say, Bears Say

Bulls Say

Revenue Re-acceleration

A stronger top-line trajectory indicates improving demand for diagnostic services and supports operating scale. Sustained volume growth across routine and specialized testing can reinforce Metropolis's market reach over the next several quarters.

Strong Cash Generation

Reliable positive cash generation gives the company internal funding for laboratory capacity, collection-network expansion and technology investment. The FY2026 improvement also strengthens resilience without relying heavily on external financing.

Conservative Leverage

Modest leverage and steadily growing equity provide financial flexibility for investment or acquisitions while limiting balance-sheet risk. This capitalization should help Metropolis withstand demand or cost volatility across the diagnostic cycle.

Bears Say

Profitability Below Prior Peak

Earnings have not kept pace with the expanded revenue base, indicating that cost control, pricing or service mix may be limiting operating leverage. Persistent margin variability could constrain the durability of future profit growth.

Volatile Cash Conversion

Although total cash generation is positive, inconsistent conversion from reported earnings can make funding capacity less predictable. Working-capital swings or collection timing may reduce the reliability of reinvestment and debt-servicing planning.

FY2026 Debt Increase

The recent debt increase introduces a need to monitor whether borrowing supports productive expansion or reflects rising funding requirements. Even with low leverage today, continued increases could gradually reduce financial flexibility.

Metropolis Healthcare Ltd. News

METROPOLIS FAQ

What was Metropolis Healthcare Ltd.’s price range in the past 12 months?
Metropolis Healthcare Ltd. lowest stock price was ₹413.00 and its highest was ₹608.95 in the past 12 months.
What is Metropolis Healthcare Ltd.’s market cap?
Metropolis Healthcare Ltd.’s market cap is ₹116.19B.
When is Metropolis Healthcare Ltd.’s upcoming earnings report date?
Metropolis Healthcare Ltd.’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 97 days.
How were Metropolis Healthcare Ltd.’s earnings last quarter?
Metropolis Healthcare Ltd. released its earnings results on Nov 03, 2026. The company reported ₹3.605 earnings per share for the quarter, beating the consensus estimate of ₹3.348 by ₹0.257.
Is Metropolis Healthcare Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Metropolis Healthcare Ltd. pay dividends?
Metropolis Healthcare Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.35%. See more information on Metropolis Healthcare Ltd. dividends here
What is Metropolis Healthcare Ltd.’s EPS estimate?
Metropolis Healthcare Ltd.’s EPS estimate is 2.83.
How many shares outstanding does Metropolis Healthcare Ltd. have?
Metropolis Healthcare Ltd. has 207,453,870 shares outstanding.
What happened to Metropolis Healthcare Ltd.’s price movement after its last earnings report?
Metropolis Healthcare Ltd. reported an EPS of ₹3.605 in its last earnings report, beating expectations of ₹3.348. Following the earnings report the stock price went up 1.544%.
Which hedge fund is a major shareholder of Metropolis Healthcare Ltd.?
Currently, no hedge funds are holding shares in IN:METROPOLIS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology